HPASMC are isolated from human pulmonary arteries. HPASMC are cryopreserved at passage one and delivered frozen. Each vial contains >5 x 105 cells in 1 ml volume. HPASMC are characterized by immunofluorescence with antibodies specific to α-smooth muscle actin and desmin. HPASMC are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HPASMC are guaranteed to further expand for 15 population doublings under the conditions provided.
Recommended Medium: It is recommended to use Smooth Muscle Cell Medium (SMCM, Cat. no. SC1101) for culturing HPASMC in vitro.
Product Use: HPASMC are for research use only. They are not approved for human or animal use, or for application in in vitro diagnostic procedures.
Storage: Upon receiving, directly and immediately transfer the cells from dry ice to liquid nitrogen and keep the cells in liquid nitrogen until they are needed for experiments.
Shipping: Dry ice.
Reference: [1] Schwartz, S. M., Campbell, G. R., Campbell, J. H. (1986) Replication of smooth muscle cells in vascular disease. Circ. Res. 58:427-444.
[2] Fan, Q. I., Vanderpool, K., Marsh, J. D. (2002) A 27 bp cis-acting sequence is essential for L-type calcium channel alpha(1C) subunit expression in vascular smooth muscle cells. Biochim Biophys Acta. 1577:401-11.
[3] Braun, M., Pietsch, P., Schror, K., Baumann, G., Felix, S. B. (1999) Cellular adhesion molecules on vascular smooth muscle cells. Cardiovasc. Res. 41:395-401.
[4] Quinn, T. P., Schlueter, M., Soifer, S. J., Gutierrez, J. A. (2002) Cyclic mechanical stretch induces VEGF and FGF-2 Expression in pulmonary vascular smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 282:L897-903.
[5] Rose, F., et al. (2002) Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells: role of hypoxia-inducible transcription factors. FASEB J. 12:1660-1.